/Companies

SUN GENOMICS

Joliet, US · Founded 2016 · 9 employees on LinkedIn · 3 known investors

Find your way into SUN GENOMICS

Sign up to see every warm intro you have to SUN GENOMICS

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the SUN GENOMICS team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Flore creates personalized probiotics based on individual microbiome sequencing, analyzing gut health markers to formulate targeted probiotic blends for each customer. The company serves consumers seeking customized solutions for digestive and gut-brain health issues.

Founders & leadership

SUN GENOMICS was founded in 2016 by Suneer Jain.

SJSuneer Jain
Suneer JainCEO and FounderSuneer Jain brings 30 years of experience in molecular and microbiology, with 20 years in laboratory and operations management, including a decade in executive roles. His background spans P&L management, clinical R&D, clinical trials, assay development, and regulatory compliance across CLIA, CAP, and GLP standards.
CR
Craig RouskeyCEOHe brings over 20 years of experience in molecular biology, immunology, and medical microbiology, previously serving as co-founder and CEO of renegade.bio, a precision diagnostics company.
MCMegan Crocker
Megan CrockerCOO, Flore Inc.Megan Crocker is Chief Operating Officer and Compliance Officer at Flore Inc., a company developing personalized probiotics based on individual microbiome sequencing. She focuses on building operational processes, quality management systems, and standard operating procedures to support the company's growth and regulatory compliance.
RSRandy Socol
Randy SocolExecutive

Investors · 3

Reported raises · per SEC filings

Form D private placements

$3.6M disclosed across 2 rounds · 2018

▶$3MraisedJan 2019 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randy SocolExecutive Officer
  • Suneer JainExecutive Officer, Director
Offering amount
$3.8M
Amount sold
$3M
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$625KraisedSep 2018 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randy SocolExecutive Officer
  • Suneer JainExecutive Officer, Director
Offering amount
$625K
Amount sold
$625K
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does SUN GENOMICS do?
Flore creates personalized probiotics based on individual microbiome sequencing, analyzing gut health markers to formulate targeted probiotic blends for each customer. The company serves consumers seeking customized solutions for digestive and gut-brain health issues.
Who founded SUN GENOMICS?
SUN GENOMICS was founded by Suneer Jain in 2016.
Who are SUN GENOMICS's investors?
SUN GENOMICS's investors include Danone Manifesto Venture, Pangaea Ventures Us Inc., SOSV.
How much funding has SUN GENOMICS raised?
SUN GENOMICS has disclosed $3.6M raised across 2 rounds.
Where is SUN GENOMICS headquartered?
SUN GENOMICS is headquartered in Joliet, US.